2018
DOI: 10.3389/fimmu.2017.02010
|View full text |Cite
|
Sign up to set email alerts
|

Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro

Abstract: Glycosylation of host and viral proteins is an important posttranslational modification needed to ensure correct function of glycoproteins. For this reason, we asked whether inhibition of O-glycosylation during human immunodeficiency virus (HIV) in vitro replication could affect HIV infectivity and replication rates. We used benzyl-2-acetamido-2-deoxy-α-d-galactopyranoside (BAGN), a compound that has been widely used to inhibit O-glycosylation in several cell lines. Pretreatment and culture of PHA-blast target… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 61 publications
0
5
0
Order By: Relevance
“…However, qVOA is time intensive and requires large amounts of biological specimen. In addition, qVOA may actually underestimate the size of the clinically relevant reservoir due to sampling limitations of latently infected reservoir cells from the most critical body compartments and the inability to reactivate all intact virus-carrying cells in vitro [20]. As an alternative to qVOA, different assays are now available to determine the inducible HIV reservoir and the viral transcriptional activity, including TILDA (Tat/Rev-induced limiting dilution assay) [16], IPDA (intact pro-viral DNA assay) and Quadruplex qPCR (Q4PCR, [18,21,22].…”
Section: Viral Reservoir As a Major Obstacle For Hiv Curementioning
confidence: 99%
“…However, qVOA is time intensive and requires large amounts of biological specimen. In addition, qVOA may actually underestimate the size of the clinically relevant reservoir due to sampling limitations of latently infected reservoir cells from the most critical body compartments and the inability to reactivate all intact virus-carrying cells in vitro [20]. As an alternative to qVOA, different assays are now available to determine the inducible HIV reservoir and the viral transcriptional activity, including TILDA (Tat/Rev-induced limiting dilution assay) [16], IPDA (intact pro-viral DNA assay) and Quadruplex qPCR (Q4PCR, [18,21,22].…”
Section: Viral Reservoir As a Major Obstacle For Hiv Curementioning
confidence: 99%
“…Finally, to assess whether hTREK-1 channel subunits might be subjected to O -glycosylation, plasmid DNA encoding WT and completely N -glycosylation-deficient N110Q/N134Q channel subunits was transiently transfected into HEK-293T cells. Subsequently, the cells were treated with the O -glycosylation inhibitor benzyl 2-acetamido-2-deoxy-α- d -galactopyranoside (BenGal), which acts as a mimic of GalNAc-α-1- O -serine/threonine and thus completely inhibits O -glycan chain extension by blocking the β-1,3-galactosyltransferase involved in elongation of O -glycosides [44,45,46]. In a subset of samples, protein lysates were subjected to digestion with O -glycosidase.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, it was discovered that the administration of benzyl‐2‐acetamido‐2‐deoxy‐α‐ d ‐galactopyranoside (BAGN), an inhibitor of O‐glycosylation commonly used in various cell lines, resulted in an elevated proportion of HIV‐infected cells, an increased quantity of HIV p24 protein per cell, and higher levels of viral particles in supernatants. This finding could potentially offer new perspectives on therapeutic targets related to O‐glycosylation for strategies aimed at controlling HIV 112 .…”
Section: Exploiting Viral O‐glycosylation In Therapies: Friend or Foementioning
confidence: 89%